InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.07
(
0.90%
)
US TECH 100
19,383.20
(
-0.56%
)
Dow Jones
42,352.75
(
0.81%
)
Brent Oil
79.72
(
3.02%
)
Bitcoin
62,792.92
(
-0.04%
)
Post# of 4764
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: None

Wednesday, 03/28/2007 11:09:29 PM

Wednesday, March 28, 2007 11:09:29 PM

Post# of 4764
In BMY's presentation, they talk about adnectins (it is the first time that I have heard of this class of proteins). My understanding is that that are a modified protein structure with antibody-like specificity. It looks like BMY is targeting adnectins to EGFR, VEGFR, and IGFR. Comments appreciated.

biophud
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up